Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2003

01-06-2003 | Original Articles

Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease

Authors: Dr. Mary McGrae McDermott, MD, Philip Greenland, MD, Jack M. Guralnik, MD, PhD, Kiang Liu, PhD, Michael H. Criqui, MD, MPH, William H. Pearce, MD, Cheeling Chan, MS, Joseph Schneider, MD, PhD, Leena Sharma, MD, Lloyd M. Taylor, MD, Adnan Arseven, MD, Maureen Quann, BS, Lillian Celic, BS

Published in: Journal of General Internal Medicine | Issue 6/2003

Login to get access
Metadata
Title
Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease
Authors
Dr. Mary McGrae McDermott, MD
Philip Greenland, MD
Jack M. Guralnik, MD, PhD
Kiang Liu, PhD
Michael H. Criqui, MD, MPH
William H. Pearce, MD
Cheeling Chan, MS
Joseph Schneider, MD, PhD
Leena Sharma, MD
Lloyd M. Taylor, MD
Adnan Arseven, MD
Maureen Quann, BS
Lillian Celic, BS
Publication date
01-06-2003
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 6/2003
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1046/j.1525-1497.2003.20527.x

Other articles of this Issue 6/2003

Journal of General Internal Medicine 6/2003 Go to the issue

Announcement

Announcement

Original Articles

Referral gridlock

Reflections

Caretaking

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine